Home
Careers
Conferences
Directory
Drug Discovery
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Virtual Pharma - the radical route to success
2.
Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)
Best Sellers:
1.
BioNewsCast Press Release Distribution Service
2.
Latest Chinese Regulations for Imported Drug Registration A Comprehensive Guidebook for Foreign Pharmaceutical Companies
3.
5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production, March 2008
4.
Microarray Markets
5.
Neuropatic Pain - Three Course Suite
6.
Contract Research Annual Review 2008
7.
Latest Chinese Regulations for Imported Drug Registration
8.
Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply
Cancer Therapeutics Markets
Cancer is the second leading cause of death by disease in the United States, exceeded only by heart disease. Traditionally cancer has been treated with surgery, chemotherapy, hormones and radiation therapy, alone or in combination. Emerging technologies include photodynamic therapy, gene therapy, biological therapy (immunotherapy) and angiogenesis inhibitors. Pharmaceutical and biotechnology companies are investing billions of dollars to search out and develop weapons for the arsenal in the war against cancer. This TriMark Publications report provides an overview of the global market for cancer therapeutics. The examination focuses on the efforts of biotechnology companies and pharmaceutical firms to incorporate new technologies for developing anti-cancer drugs into their corporate strategies. This study examines cancer therapeutic products now on the market, as well as those currently under development that might be commercialized in the near future. Additionally, the report profiles a number of firms that are actively involved in marketing and developing of products to be used in the treatment of cancer-both large multinational corporations. The analysis also provides an overview of the disease and data on cancers by site or type. It provides incidence and mortality data for different types of the disease. In addition, the report provides a summary of each of the therapies that are being used to treat cancer.
Publication Date: 01-MAY-08
Pages: 182
Study: TMRCTH
Format/Price: PDF document / $3,400.00
Table of Contents
Price: $3,400.00 / GBP1,870.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.